Healthcare Associated Infection Reports

From HL7Wiki
Jump to: navigation, search

This wiki page supports the collaborative work on the Clinical Document Architecture (CDA) for reporting of Healthcare Associated Infections between HL7, CDC and other interested stakeholders. The primary use case for this project is the CDC's National Healthcare Safety Network (NHSN), which has specified a number of Healthcare Associated Infection (HAI) reports. These reports are now available in electronic CDA format with published HL7 Implementation Guides.

Announcements

24th August 2016 - NHSN HAI R3D1.1 Available for Comment

An update has been made to the NHSN HAI CDA Implementation Guide.

This update is NHSN Healthcare Associated Infection (HAI) Reports Release 3, DSTU 1.1—US Realm, 1st Update to 1st HL7 Draft Standard for Trial Use (DSTU) (NHSN HAI R3D1.1). This update is available to HL7 members here: http://www.hl7.org/documentcenter/public/wg/structure/CDAR2_IG_HAIRPT_R3_D1.1_2016AUG_UPDATE_FOR_COMMENT.zip as a point release for commenting prior to reconciliation and publication.

As a DSTU update, this new version will not go through the usual HL7 balloting process but will use the DSTU Update process with industry review on the HL7 wiki.

The full list of changes in this release is documented in the update and can be summarized as:

Three reports were revised:

  1. HAI Evidence of Infection (Dialysis) Report (V5)
  2. Hemovigilance (HV) Summary Report (V2)
  3. HAI AUR Antimicrobial Resistance Option (ARO) Report (V4)

Two new templates were added:

  1. Blood Sample Collected for Culture Observation
  2. Pathogen Reduced Apheresis Platelet Usage Summary Observation

Fourteen templates were revised:

  1. Antimicrobial Susceptibility Result Observation (V3)
  2. Antimicrobial Susceptibility Result Organizer (V3)
  3. Antimicrobial Susceptibility Tests Organizer (V3)
  4. Blood Product Usage Summary Observation (V2)
  5. Facility Transfuses Blood Products Treated with Pathogen Reduction Technology Observation (V2)
  6. Infection Indicator Organizer (V4)
  7. ISBT Product Code Summary Observation (V2)
  8. Isolate Susceptibility Tests Organizer (V3)
  9. IV Antibiotic Start Clinical Statement (V3)
  10. Specimen Collection Procedure (ARO) (V3)
  11. Summary Encounter (HV) (V2)
  12. Details Section in an Evidence of Infection (Dialysis) Report (V5)
  13. Findings Section in an ARO Report (V3)
  14. Summary Data Section (HV) (V2)

Twelve new value sets were added:

  1. NHSN Red Blood Cells/Whole Blood Derived/S-303-Treated
  2. NHSN Red Blood Cells/Whole Blood Derived/Riboflavin-Treated
  3. NHSN Red Blood Cells/Apheresis/S-303-Treated
  4. NHSN Red Blood Cells/Apheresis/Riboflavin-Treated
  5. NHSN Cryoprecipitate/Psoralen-Treated
  6. NHSN Cryoprecipitate/Riboflavin-Treated
  7. NHSN Platelets/Apheresis/Psoralen-Treated and In Plasma
  8. NHSN Platelets/Apheresis/Psoralen-Treated and In Platelet Additive Solution
  9. NHSN Platelets/Apheresis/Riboflavin-Treated and In Plasma
  10. NHSN Platelets/Apheresis/Riboflavin-Treated and In Platelet Additive Solution
  11. NHSNPathogenReducedApheresisPlateletUsage
  12. NHSNDrugSusceptibilityTestMethod

Six value sets were revised:

  1. NHSNHealthcareServiceLocationCode
  2. NHSNPathogenCode
  3. NHSNSpecimenTypeCode
  4. NHSNDrugSusceptibilityTestsCode
  5. NHSNCdiffTestMethod
  6. NHSNCriterionOfDiagnosisCode

During the two week comment period running from Wednesday 24 August 2016 - Wednesday 7 September 2016, please submit your comments here: NHSN HAI R3D1.1 Comments including at least your name, item, existing wording, proposed wording, and comment. Thank you.


30th September 2014 - NHSN R2D2.1 Available for Comments

An update has been made to the NHSN Healthcare Associated Infection Reports, Release 2, US Realm, September 2013, 2nd DSTU Ballot (NHSN HAI R2D2). This update is available to HL7 members here http://www.hl7.org/documentcenter/public/wg/structure/20140924_Draft_for_Comment_CDAR2_IG_HAIRPT_R2_D2_1_2014SEPT_V2.zip as a point release named NHSN HAI R2D2.1 for commenting prior to reconciliation and publication. As a DSTU update, this new version will not go through the usual HL7 balloting process but will use the DSTU Update process with industry review on the HL7 wiki. The full list of changes in this release is documented in the update and can be summarized as:

  1. No reports were added or removed.
  2. Eleven new templates were added:
    1. Antimicrobial Coated Catheter Used Observation
    2. Bacterial Isolate Tested for Carbapenemase Observation
    3. Blood Collection Location
    4. Carbapenemase Test Observation
    5. Carbapenemase Test Organizer
    6. Carbapenemase Type Identified Observation
    7. Contraindication Type Observation
    8. Last Physical Overnight Location
    9. Other Facility Discharge Encounter
    10. Positive Test for Carbapenemase Observation
    11. Primary C. Difficile Testing Method This Quarter
  3. One new value set was added:
    1. NHSNArDrugSuscTestsCode (2.16.840.1.114222.4.11.7230)

During the two week comment period running from 1st October 2014 - 14th October 2014, please submit your comments here: NHSN HAI R2D2.2 Comments including at least your name, item, existing wording, proposed wording, and comment. Thank you.


31st Jan 2014 - NHSN R2D1.1 Available for Comments

A minor update has been made to the NHSN Healthcare Associated Infection Reports, Release 2, US Realm, September 2013, 1st DSTU Ballot (NHSN HAI R2D1). This update is available to HL7 members here CDAR2_IG_HAIRPT_R2_D1_1_2014JAN.zip as a point release named NHSN HAI R2D1.1 for commenting prior to reconciliation and publication. As a minor DSTU update, this new version will not go through the usual HL7 balloting process but will use the DSTU Update process with industry review on the HL7 wiki. Because no changes were made to templates in this update, comments involving template modification are not in scope. The full list of changes in this release is documented in the update and can be summarized as:

  1. Formatting the guide into two volumes
  2. Value set changes to NHSNCriterionOfDiagnosisCode

During the two week comment period running from 1/31/2014 - 2/13/2014, please submit your comments here: NHSN HAI R2D1.1 Comments including at least your name, item, existing wording, proposed wording, and comment. Thank you.


9th Sep 2009 - Errata to the 2009 R2 DSTU

CONF-382: width element representing the duration of procedure is no longer required. The NHSN is planning a go-live for 9/14/2009 on BSI, SSI and Procedure Denominator


25th June 2009 - New Schematron Package

Schematron package for the 2009 R2

Please consult with NHSN for subsequent updates.

Copyright © Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publisher.